![Caspar Graf Stauffenberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Caspar Graf Stauffenberg
Vorstandsvorsitzender bei Aequos Endoprothetik GmbH
Profil
Caspar Graf Stauffenberg is currently a Member-Supervisory Board at Proteros biostructures GmbH, Co-Managing Partner at Aequos Endoprothetik GmbH, and Co-Managing Partner at Carlsquare GmbH.
Previously, he worked as the Chief Executive Officer at ResMed R&D Germany GmbH and as a Manager-Strategy & Organization Practice at Arthur D.
Little GmbH.
Aktive Positionen von Caspar Graf Stauffenberg
Unternehmen | Position | Beginn |
---|---|---|
Carlsquare GmbH
![]() Carlsquare GmbH Investment ManagersFinance CatCap GmbH provides strategic corporate action planning and consulting services. The firm supports businesses and shareholders in dealing with corporate issues, such as shares disposal, acquisition and equity capitalization, and business portfolio optimization. Its focus areas encompass merger and acquisitions, capital-raising, management buy-in and buy-out activities. It operates as a corporate finance consultancy firm, which enables clients to identify and acquire partners or additional purchases and investments. It operates a network of strategic and financial investors, family offices, and management buy-in candidates. The company was founded by Mark Miller and Michael Moritz in 2000 and is headquartered in Hamburg, Germany. | Corporate Officer/Principal | - |
Aequos Endoprothetik GmbH | Vorstandsvorsitzender | - |
Proteros biostructures GmbH
![]() Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Proteros biostructures GmbH is a holding company which serves as a discovery service business. Its business areas are Discovery Pipeline, Discovery Services and Science & Technology. The Discovery Pipeline focuses on protein biochemistry, X-ray crystallography, biophysics, computational chemistry and property driven medicinal chemistry, Discovery Services offers drug discovery services with expertise and proprietary technologies for protein production, protein structure analysis, kinetic and thermodynamic profiling and Science & Technology segment focuses on industrialized structure-guided lead development infrastructure. The company was founded by Robert Huber and Torsten Neuefeind in 1999 and is headquartered in Martinsried, Germany. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Caspar Graf Stauffenberg
Unternehmen | Position | Ende |
---|---|---|
ResMed R&D Germany GmbH
![]() ResMed R&D Germany GmbH Medical SpecialtiesHealth Technology Part of ResMed, Inc., ResMed R&D Germany GmbH is a company that designs, manufactures, and distributes medical devices for the diagnosis and treatment of sleep-disorder breathing. The company is based in Martinsried, Germany. The company was founded in 1998. Martin Klaus Schmausser has been the CEO of the company since 2018. ResMed R&D Germany was acquired by ResMed, Inc. on February 20, 2001 for $69 million. | Vorstandsvorsitzender | - |
Arthur D. Little GmbH
![]() Arthur D. Little GmbH Miscellaneous Commercial ServicesCommercial Services Part of Capgemini SE, Arthur D. Little GmbH is a company based in Frankfurt, Germany. The German company facilitates cross-sectoral exchange of energy data and links people, technology & strategy to find original and pragmatic ways to accelerate performance. The company also provides CVC considerations to put industrial companies in the lead. The CEO of the company is Fabian Dömer. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Carlsquare GmbH
![]() Carlsquare GmbH Investment ManagersFinance CatCap GmbH provides strategic corporate action planning and consulting services. The firm supports businesses and shareholders in dealing with corporate issues, such as shares disposal, acquisition and equity capitalization, and business portfolio optimization. Its focus areas encompass merger and acquisitions, capital-raising, management buy-in and buy-out activities. It operates as a corporate finance consultancy firm, which enables clients to identify and acquire partners or additional purchases and investments. It operates a network of strategic and financial investors, family offices, and management buy-in candidates. The company was founded by Mark Miller and Michael Moritz in 2000 and is headquartered in Hamburg, Germany. | Finance |
Arthur D. Little GmbH
![]() Arthur D. Little GmbH Miscellaneous Commercial ServicesCommercial Services Part of Capgemini SE, Arthur D. Little GmbH is a company based in Frankfurt, Germany. The German company facilitates cross-sectoral exchange of energy data and links people, technology & strategy to find original and pragmatic ways to accelerate performance. The company also provides CVC considerations to put industrial companies in the lead. The CEO of the company is Fabian Dömer. | Commercial Services |
ResMed R&D Germany GmbH
![]() ResMed R&D Germany GmbH Medical SpecialtiesHealth Technology Part of ResMed, Inc., ResMed R&D Germany GmbH is a company that designs, manufactures, and distributes medical devices for the diagnosis and treatment of sleep-disorder breathing. The company is based in Martinsried, Germany. The company was founded in 1998. Martin Klaus Schmausser has been the CEO of the company since 2018. ResMed R&D Germany was acquired by ResMed, Inc. on February 20, 2001 for $69 million. | Health Technology |
Aequos Endoprothetik GmbH | |
Proteros biostructures GmbH
![]() Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Proteros biostructures GmbH is a holding company which serves as a discovery service business. Its business areas are Discovery Pipeline, Discovery Services and Science & Technology. The Discovery Pipeline focuses on protein biochemistry, X-ray crystallography, biophysics, computational chemistry and property driven medicinal chemistry, Discovery Services offers drug discovery services with expertise and proprietary technologies for protein production, protein structure analysis, kinetic and thermodynamic profiling and Science & Technology segment focuses on industrialized structure-guided lead development infrastructure. The company was founded by Robert Huber and Torsten Neuefeind in 1999 and is headquartered in Martinsried, Germany. | Health Services |